Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study

CONCLUSION: For patients with stage I, low-grade EEC, abnormal p53 expression may be used as an indicator of poor prognosis. Therefore, we suggest considering aggressive adjuvant therapies for these patients.PMID:38576345 | DOI:10.3802/jgo.2024.35.e78

Source: Journal of Gynecologic Oncology - April 5, 2024 Category: OBGYN Authors: Yu-Wei Chang Hsiao-Li Kuo Tzu-Chien Chen Jessica Chen Ling Lim Kung-Liahng Wang Jen-Ruei Chen Source Type: research